Cefdinir versus amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 3, 1997, Pages 214-219

  Adler, M ^a   McDonald, P J ^b   Trostmann, U ^c   Keyserling, C ^d   Tack, K ^d  

^a Belmont Health Centre   (United Kingdom)

^b FLINDERS UNIVERSITY   (Australia)

^c Parke Davis International Clinical Development   (Germany)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFDINIR;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG SAFETY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SECRETORY OTITIS MEDIA; SINGLE BLIND PROCEDURE; VOMITING;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CLAVULANIC ACID; CLAVULANIC ACIDS; DIARRHEA; FEMALE; HUMANS; INFANT; MALE; OTITIS MEDIA, SUPPURATIVE; PENICILLINS;

EID: 0031001666     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01709584     Document Type: Article

References (9)

1. Klein JO: Otitis media. Clinical Infectious Diseases 1994, 19: 823-833.
2. Management of acute otitis media and glue ear. Drug and Therapeutic Bulletin 1995, 33: 12-15.
3. Briggs BM, Jones RN, Erwin ME, Barrett MS, Johnson DM: In vitro activity evaluations of cefdinir (FK 482, Cl-983 and PD 134393): A novel orally administered cephalosporin. Diagnostic Microbiology and Infectious Disease 1991, 14: 425-434.
4. Wise R, Andrews JM, Thornber D: The in vitro activity of cefdinir (FK 482), a new oral cephalosporin. Journal of Antimicrobial Chemotherapy 1991, 28: 239-248.
5. Sultan T, Baltch AL, Smith RP, Ritz W: In vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolated from adult and pediatric patients. Chemotherapy 1994, 40, Supplement 2: 80-91.
6. Shinozaki T: Clinical studies of cefdinir in pediatric infections. Japanese Journal of Antibiotics 1991, 44: 1087-1095.
7. Cohen MA, Joannides ET, Roland GE, Meservey MA, Huband MD, Shapiro MA, Sesnie JC, Heifetz CL: In vitro evaluation of cefdinir (FK 482), a new oral cephalosporin with enhanced antistaphylococcal activity and β-lactamase stability. Diagnostic Microbiology and Infectious Disease 1994, 18: 31-39.
8. Poole JM, Rosenberg R, Aronovitz GH, Horowitz DA, Latiolais TG, Schaeffer CI, Disney F, De la Garza CA, Mendel P, Parks BR, Rogan MP: Cefprozil vs. cefixime and cefaclor in otitis media in children. Infections in Medicine 1992, 9, Supplement E: 19-32.
9. Hussar DA: Importance of patient compliance in effective antimicrobial therapy. Pediatric Infectious Disease Journal 1987, 10: 971-975.